课题基金 / 基金详情

Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery

Refining the Tourette Syndrome phenotype across diagnoses to aid gene discovery
改进抽动秽语综合症的诊断表型以帮助基因发现
批准号:
8763948
负责人:
Carol A Mathews
金额:
$32.2万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-01-23 至 2015-07-31

项目摘要

项目成果

Carol A Mathews的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposed research leverages a large clinical and genetic dataset of individuals and families with Tourette Syndrome (TS) to identify heritable symptom-based phenotypes and conduct quantitative genome-wide association studies (qGWAS) with the ultimate goal of identifying genetic variants that contribute to TS susceptibility. TS is a complex developmental neuropsychiatric disorder that affects 1/150 to 1/300 children world-wide. Although the core features of TS (the presence of motor and vocal tics) are fairly straightforward, TS is phenotypically diverse, with some individuals manifesting only mild tics with little to no functional impact and others manifesting moderate to severe tics with marked impairment. Individuals at all levels of tic severity and in all age groups may also experience a range of co-occurring conditions that lead to significant functional impairment, most commonly obsessive-compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD), but also including other mood, anxiety, and disruptive behavior disorders. This phenotypic heterogeneity has complicated etiological and treatment studies of TS, as well as impacting clinical care. This study will use novel analytic approaches such as factor mixture modeling to 1) examine the frequencies, patterns, and correlates of co-occurring psychiatric disorders, 2) identify TS phenotypic subtypes based on patterns of tic and related symptoms and co-occurring conditions (including autism spectrum symptoms), 3) examine the heritabilites and transmission patterns of these subphenotypes, and 4) conduct quantitative genome-wide association studies with the most heritable of the identified subphenotypes. We have extensive clinical data (lifetime and current symptomatology) on over 2,100 TS-affected individuals and 2,500 of their biological first-degree relatives, as well as genome-wide genetic data on 1006 of the TS cases, providing an unparalleled opportunity to further our understanding of the presentation TS. The work proposed in this application has relevance both clinically, as we will be able to determine rates and patterns of co-occurring disorders, which, as mentioned, are responsible for the majority of the impairment in TS, and scientifically, as it provides additional avenues for genetic and other investigations into the etiology and pathophysiology of TS and other related neurodevelopmental disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome
  • 批准号:
    9904780
  • 项目类别:
  • 资助金额:
    $58.32万
  • 财政年份:
    2019
  • 负责人:
    Carol A Mathews
  • 依托单位:
Large-Scale Collaborative Genetic and Epigenetic Studies of Tourette Syndrome
  • 批准号:
    10559565
  • 项目类别:
  • 资助金额:
    $56.93万
  • 财政年份:
    2019
  • 负责人:
    Carol A Mathews
  • 依托单位:
Large-scale collaborative genetic and epigenetic studies of Tourette Syndrome
  • 批准号:
    10377902
  • 项目类别:
  • 资助金额:
    $57.27万
  • 财政年份:
    2019
  • 负责人:
    Carol A Mathews
  • 依托单位:
Admin Supp for A phased clinical trial of a dietary supplement kava: biomarker changes and anxiolytic effects
  • 批准号:
    10223742
  • 项目类别:
  • 资助金额:
    $6.82万
  • 财政年份:
    2019
  • 负责人:
    Carol A Mathews
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: